Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
57 studies found for:    "Temporal arteritis"
Show Display Options
Rank Status Study
21 Completed Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
Conditions: Takayasu's Arteritis;   Giant Cell Arteritis
Interventions: Drug: Abatacept;   Drug: Placebo
22 Completed Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)
Condition: Giant Cell Arteritis
Interventions: Procedure: Ultrasound of temporal and axillary arteries;   Procedure: Temporal artery biopsy
23 Recruiting Validation of a Diagnostic Algorithm of Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Other: color Doppler ultrasound and TAB in case of CDU negative
24 Recruiting Improving the Diagnosis and Prognostication of GCA Through the Novel Use of PET Scan and Immune Biomarkers
Condition: Giant Cell Arteritis
Intervention:
25 Completed Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
Conditions: Takayasu's Arteritis;   Giant Cell Arteritis;   Arteritis;   Vasculitis;   Aortitis
Intervention:
26 Recruiting Baricitinib in Relapsing Giant Cell Arteritis
Condition: Arteritis, Giant Cell
Intervention: Drug: Baricitinib
27 Recruiting Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease
Condition: Horton's Disease
Intervention: Biological: Blood samples
28 Recruiting Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease
Condition: Horton Disease
Interventions: Radiation: Vascular tomodensitometry;   Other: Magnetic resonance angiography;   Other: Vascular ultrasonography;   Other: Retinal angiography;   Other: Retinal optical coherence tomography
29 Unknown  Study of the T CD8 Immune Response in Horton's Disease
Condition: Horton's Disease
Interventions: Other: Blood sample drawn into a 5 mL dry tube at the diagnosis and after 3 months of treatment;   Other: 16 blood samples drawn into 6 mL heparinized tubes at the diagnosis and after 3 months of treatment;   Other: Blood sample drawn into a 5 mL dry tube;   Other: 16 blood samples drawn into 6 mL heparinized tubes
30 Unknown  Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Horton's Disease: Proof of Concept Study.
Condition: Horton's Disease
Intervention: Drug: corticoids+ tocilizumab 8mg/Kg/month
31 Recruiting Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE
Condition: Polymyalgia Rheumatica
Interventions: Drug: Tocilizumab;   Drug: Placebo
32 Not yet recruiting Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone /Prednisone placebo
33 Completed Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Intervention: Drug: tocilizumab
34 Terminated Delayed Release Prednisone in PMR
Condition: Polymyalgia Rheumatica
Interventions: Drug: Delayed-Release (DR) Prednisone;   Drug: Immediate Release (IR) Prednisone
35 Terminated A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR
Condition: Polymyalgia Rheumatica
Interventions: Drug: Lodotra®;   Drug: Prednisone IR (immediate release)
36 Completed Tocilizumab Effect iN pOlymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Intervention: Drug: TCZ
37 Unknown  Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: infliximab;   Drug: inactive powder
38 Completed Study of Tocilizumab to Treat Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica (PMR)
Intervention: Drug: Tocilizumab
39 Terminated
Has Results
A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica
Conditions: Polymyalgia Rheumatica;   Inflammatory Diseases
Interventions: Drug: AIN457;   Drug: ACZ885;   Drug: Prednisone;   Drug: Placebo
40 Completed Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients
Condition: Polymyalgia Rheumatica
Intervention: Drug: prednisone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-57) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.